Azitra
AZTR • AMEX
Azitra is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Francisco D. Salva, with a market cap of $3.9M.
CEOFrancisco D. Salva
Next Earnings
Upcoming earnings announcement for Azitra
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.45
Earnings History
Past 11 earnings reports for Azitra
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Q4 2025 | -$0.81Est: -$0.34 | -138.2% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.67Est: -$0.78 | +14.1% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.18Est: -$0.08 | -125.0% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.23 | — | - | — | 10-Q |
| Feb 24, 2025 | Q4 2024 | -$0.31Est: -$0.50 | +38.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.17Est: -$0.36 | +52.8% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$2.74 | — | $75.0K | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$4.50 | — | - | — | 10-Q |
| Mar 15, 2024 | Q4 2023 | $4.20Est: -$5.40 | +177.8% | $90.0K | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$4.80 | — | $310.7K | — | — |
| Aug 14, 2023 | Q2 2023 | -$70.80 | — | $172.0K | — | — |